Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Regulatory News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
11.50    -0.25 (-2.13%)
Bid:
11.00
Ask:
12.00
Spread: 1.00 (9.091%)
Market Cap: £14.39m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Acquisition

4 Jun 2007 07:02

Fabian Romania Property Fund Ltd04 June 2007 Fabian Romania Property Fund Limited ("Fabian Romania" or the "Fund") Fabian Romania announces the purchase of a €4.9 million office building inBucharest Fabian Romania has reached agreement to purchase the Evocenter office buildingin the Pipera / Voluntari district of Bucharest for a forecast yield of 9 percent.. The Evocenter will be the Fund's fourth office building in Bucharest. The fund had initially proposed to purchase the building empty, thereby takingthe letting risk. However, during the due diligence process, the Adama Groupfrom Israel, the developer, signed a lease taking half of the available space.The building will be completed in summer 2007 to a Class A standard andcomprises 3,000m2 of net lettable area, 18 covered car parking spaces andancillary parking close by. It is arranged over seven levels, basement, groundfloor, mezzanine and four office floors. Rents that will be achieved for the building are forecast to be €12 sqm/monthfor ground, mezzanine and floors one to four, €65 sqm/month for parking and €7sqm/month for storage. Once all space is fully let, the yield is forecast to be9 per cent.. The Fund will meet the consideration of €4.9 million from its own resources.Debt drawdown is anticipated to be during the third quarter 2007 which willreduce the ongoing equity requirement to around €1 million. Commenting on the transaction, Mark Holdsworth, Managing Director of FabianCapital, the Investment Advisor to the Fund said: "We are delighted that the Fund has sealed agreement to buy this commercialoffice building. Based on our experience and given the ongoing shortage ofoffice space in Bucharest, we believe it is in the Fund's interest to agree totake the letting risk for the building in return for sealing a more attractiveprice. By having the Adama Group, as both anchor tenant and vendor, we consider we haveensured a quality product through the alignment of interests. We are confidentof letting the rest of the building out to multinational tenants in the nearfuture." Following the acquisition of 40-44 Banu Antonache in January 2006, the purchaseof the Adama building will be the second occasion the fund has taken the lettingrisk. The lead advisers on the transaction were DTZ (property agent), WSP (technicaladvisers) and Tuca Zbarcea Asociatii (legal adviser). For Comments: Fabian Romania:Mark Holdsworth +44 20 7499 9988 Nominated Adviser:Deloitte & Touche LLPJames Lewis +44 20 7936 3000 Broker:Shore Capital Stockbrokers LimitedDru Danford +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Nov 20202:00 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSNotice of Results
28th Oct 20204:41 pmRNSSecond Price Monitoring Extn
28th Oct 20204:36 pmRNSPrice Monitoring Extension
27th Oct 20207:00 amRNSReceipt of grants from Invest Northern Ireland
25th Sep 202011:38 amRNSResult of AGM
24th Sep 20202:39 pmRNSDirector/PDMR Shareholding
22nd Sep 20205:16 pmRNSHolding(s) in Company
18th Sep 20209:31 amRNSUpdate on R&D programme
28th Aug 20207:00 amRNSNotice of AGM
19th Aug 20207:00 amRNSFinal Results
11th Aug 20209:33 amRNSQueens University Belfast funding
31st Jul 20205:00 pmRNSTotal Voting Rights
7th Jul 20202:12 pmRNSExercise of Options
6th Jul 20204:41 pmRNSSecond Price Monitoring Extn
6th Jul 20204:36 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSTrading update
4th Jun 202012:57 pmRNSHolding(s) in Company
29th May 20205:00 pmRNSTotal Voting Rights
21st May 20206:24 pmRNSHolding(s) in Company
21st May 20202:52 pmRNSHolding(s) in Company
15th May 20204:49 pmRNSHolding(s) in Company
15th May 202010:47 amRNSResult of General Meeting & Total Voting Rights
15th May 20208:30 amRNSHolding(s) in Company
28th Apr 20207:00 amRNSPlacing to raise £3m, trading update, notice of GM
17th Apr 20204:41 pmRNSSecond Price Monitoring Extn
17th Apr 20204:35 pmRNSPrice Monitoring Extension
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:36 pmRNSPrice Monitoring Extension
16th Apr 20203:51 pmRNSResearch Alliance with Queen’s University Belfast
16th Apr 20202:06 pmRNSSecond Price Monitoring Extn
16th Apr 20202:01 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSTrading update
19th Mar 20207:00 amRNSBelfast investor presentation
17th Mar 20207:00 amRNSDirector/PDMR Shareholding
17th Feb 20207:00 amRNSBelfast investor presentation
3rd Feb 202012:01 pmRNSDirector/PDMR Shareholding
30th Jan 20204:40 pmRNSSecond Price Monitoring Extn
30th Jan 20204:35 pmRNSPrice Monitoring Extension
29th Jan 20207:00 amRNSTrading update
10th Jan 202011:47 amRNSDirector/PDMR Shareholding
3rd Dec 20199:26 amRNSDirector/PDMR Shareholding
2nd Dec 20197:00 amRNSHalf-year Report
26th Nov 201911:13 amRNSNotice of Results
22nd Oct 20197:00 amRNSHalf year trading update
26th Sep 20199:54 amRNSDirector/PDMR Shareholding
20th Sep 20192:14 pmRNSResult of AGM
21st Aug 20197:00 amRNSPosting of Annual Report & Notice of AGM
3rd Jul 20194:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.